Dr Gregory Sebepos-Rogers

Sub-specialties: Gastroenterology, Endoscopy, Inflammatory Bowel Disease, Nutrition, Irritable Bowel Syndrome.

02036532009

Overview

Dr Sebepos-Rogers is a Consultant Gastroenterologist at Welbeck and Imperial College Healthcare NHS Trust, and Honorary Senior Clinical Lecturer at Imperial College London. He has specialist interests in Inflammatory Bowel Disease, nutrition and endoscopy, and leads the nutrition service at Hammersmith Hospital.

About Dr Gregory Sebepos-Rogers

Dr Sebepos-Rogers studied medicine at UCL and completed training in Oxford and London specialist centres for IBD and nutrition. He has an MSc in genomic medicine at Imperial College London and a PhD (in submission) in immunology at University College London.

In his current practice, he cares for patients at St Marys and Hammersmith hospitals, undertakes general and specialist IBD clinics, and leads the Hammersmith site nutrition service. He is a proficient endoscopist and trainer, and participates in the advanced polyp MDT. He is site training lead for St Mary's Hospital and examiner for Imperial College London. He is a principal investigator in IBD-linked commercial studies and Honorary Clinical Senior Lecturer at Imperial College London within the Digestive Disease research group.

Areas of Expertise

Dr Gregory Sebepos-Rogers commonly treats the following conditions:

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis
Microscopic colitis
Abdominal pain
Abdominal bloating
Diarrhoea
Constipation
Rectal bleeding
Irritable Bowel Syndrome
Dyspepsia (indigestion) and reflux (heartburn)
Coeliac disease
Colorectal Polyps

He performs a range of tests and treatments including:

Colonoscopy
Gastroscopy
Sigmoidoscopy

Additional Information

Dr Gregory Sebepos-Rogers holds the following qualifications: BSC, MD, MBBS, MRCP

He is an active member of:

Member of the Royal College of Physicians (London)
British Society of Gastroenterologists
European Crohn's & Colitis Organisation
International Bowel Ultrasound Society

Dr Sebepos-Rogers is the recipient of the following professional awards:

Crohn's and Colitis UK Fellowship
Royal Free Charity Grant
Francis Crick Partnership Network Grant (London Gut-Liver Network)

Research Highlights

Sebepos-Rogers G, Sufi J, Qin X, Vlckova P, Sanders D, Murray C, Rahman FZ, Tape CJ, Smith AM. A novel autophagy-defective IBD organoid model reveals increased apoptosis and altered Paneth cell signalling in response to TNF-alpha and bacterial ligand stimulation using multiplexed in situ mass cytometry assays. Gastroenterology 2024 Volume 166, Issue 5, Supplement S-160-S-161 May 18.
Sanders, D.J., Inniss, S., Sebepos-Rogers, G., Rahman, F.Z., Smith, A.M. (2021). The role of the microbiome in gastrointestinal inflammation. Biosci Rep., June 2021 41(6) doi:10.1042/BSR20203850.
Kader, R*, Dart, RJ*, Sebepos-Rogers, G*, ..., GLINT Research Network, Segal, J, A Samaan, MA. *contributed equally. (2020). Implementation of an intervention bundle leads to quality improvement in ulcerative colitis endoscopy reporting. GastroHep, October 2020 doi:10.1002/ygh2.427.
Gadhok, R, Gordon, H, Sebepos-Rogers, G, ..., Lindsay, JO. (2020). UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients. Dig Dis Sci, 65 (6), 1790-1799. doi:10.1007/s10620-019-05907-w
Bakir IA, Sebepos-Rogers GM, Burton H, Monahan KJ. Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees. BMJ Open. 2019 Oct 22;9(10):e030505. doi: 10.1136/bmjopen-2019-030505. PMID: 31640999.

Full publication list: https://orcid.org/0000-0002-5422-323X

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.